Production (Stage)
Beta Bionics, Inc.
BBNX
$14.43
-$1.08-6.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 17.64M | 20.44M | 16.71M | 12.93M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 17.64M | 20.44M | 16.71M | 12.93M | |
| Cost of Revenue | 8.67M | 8.75M | 7.79M | 5.73M | |
| Gross Profit | 8.97M | 11.69M | 8.91M | 7.20M | |
| SG&A Expenses | 20.02M | 15.51M | 14.75M | 11.18M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 36.28M | 33.48M | 27.68M | 22.39M | |
| Operating Income | -18.64M | -13.04M | -10.98M | -9.45M | |
| Income Before Tax | -28.66M | -18.11M | -9.74M | -12.45M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -28.66M | -18.11M | -9.74M | -12.45M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -28.66M | -18.11M | -9.74M | -12.45M | |
| EBIT | -18.64M | -13.04M | -10.98M | -9.45M | |
| EBITDA | -18.34M | -12.81M | -10.67M | -9.17M | |
| EPS Basic | -0.93 | -2.72 | -1.55 | -2.07 | |
| Normalized Basic EPS | -0.58 | -1.70 | -0.97 | -1.29 | |
| EPS Diluted | -0.93 | -2.72 | -1.55 | -2.07 | |
| Normalized Diluted EPS | -0.58 | -1.70 | -0.97 | -1.29 | |
| Average Basic Shares Outstanding | 30.71M | 6.67M | 6.26M | 6.02M | |
| Average Diluted Shares Outstanding | 30.71M | 6.67M | 6.26M | 6.02M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |